Live Feed

Delayed 3m

Analyst · Buys · Leadership Updates · Large Ownership Changes

Signed out · 3-min delay · Sign up for real-time

PR21:56:00·11h·Real Estate·
$FRMI
Larry Kellerman, Fermi's Chief Power Officer and Architect of Its 17 GW Energy Infrastructure, Accepts Board Nomination
DALLAS, May 1, 2026 /PRNewswire/ -- Toby Neugebauer, co-founder and largest shareholder of Fermi America (NASDAQ & LSE: FRMI), today announced that he has nominated Larry Kellerman to join the Fermi Board of Directors. Kellerman, who serves as Chief Power Officer at Fermi America, is the architect of the Company's 17-gigawatt powered data center campus in Amarillo, Texas — the largest private energy grid in America. Kellerman is co-founder and Managing Partner of Twenty First Century Utilities and brings more than four decades of power industry and finance expertise to the role. His career spans senior leadership positions at Goldman Sachs, El Paso Corporation, and I Squared Capital. Kellerm
INSIDER21:46:56·11h·Miscellaneous·
$LASE
Director Lu Qing sold $5,684 worth of shares (5,800 units at $0.98), increasing direct ownership by 332% to 83,812 units (SEC Form 4)
4 - Laser Photonics Corp (0001807887) (Issuer)
INSIDER19:27:10·13h·Finance·
$CBK
EVP, Chief Financial Officer Metheny Philip J. bought $95,760 worth of shares (3,300 units at $29.02), increasing direct ownership by 35% to 12,732 units (SEC Form 4)
4 - Commercial Bancgroup, Inc. (0001981546) (Issuer)
INSIDER18:15:43·14h·Finance·
$AGO
Large owner Assured Guaranty Ltd bought $6,000,000 worth of Common Shares of Beneficial Interest (242,718 units at $24.72) (SEC Form 4)
4 - ASSURED GUARANTY LTD (0001273813) (Reporting)
INSIDER18:01:25·15h·Real Estate·
$AXR
Large owner Dahl James H bought $222,256 worth of shares (8,000 units at $27.78) (SEC Form 4)
4 - AMREP CORP. (0000006207) (Issuer)
PR17:05:06·15h·Health Care·
$EPRX
Eupraxia Pharmaceuticals Appoints Dr. Jeymi Tambiah as Chief Medical Officer
VANCOUVER, British Columbia, May 01, 2026 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize local, controlled drug delivery for applications with significant unmet need, today announced the appointment of Dr. Jeymi Tambiah as Chief Medical Officer (CMO) as well as the retirement of Dr. Mark Kowalski, Eupraxia's current CMO. Dr. Jeymi Tambiah (MB ChB, FRCS, MS, FAPCR, FFPM), is a Board Certified Cardiothoracic Surgeon physician scientist who practiced at Guys and St Thomas' Hospitals prior to entering the biopharmaceutical in
INSIDER16:46:39·16h·Industrials·
$CR
Director Lynch Susan D bought $26,607 worth of shares (150 units at $177.38), increasing direct ownership by 68% to 370 units (SEC Form 4)
4 - Crane Co (0001944013) (Issuer)
INSIDER16:39:37·16h·Health Care·
$PCSA
Pres. Research & Development Young David bought $4,589 worth of shares (1,706 units at $2.69), increasing direct ownership by 14% to 13,813 units (SEC Form 4)
4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
INSIDER16:38:35·16h·Health Care·
$PCSA
Chief Financial Officer Skibsted Russell bought $5,891 worth of shares (2,190 units at $2.69), increasing direct ownership by 51% to 6,498 units (SEC Form 4)
4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
INSIDER16:37:24·16h·Health Care·
$PCSA
Chief Executive Officer Ng George K bought $5,471 worth of shares (2,034 units at $2.69), increasing direct ownership by 51% to 6,013 units (SEC Form 4)
4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
INSIDER16:36:26·16h·Health Care·
$PCSA
Chief Business - Strategy Off Lin Patrick bought $4,065 worth of shares (1,511 units at $2.69), increasing direct ownership by 32% to 6,236 units (SEC Form 4)
4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
INSIDER16:35:41·16h·Health Care·
$PCSA
Chief Administrative Officer Guy Wendy bought $4,702 worth of shares (1,748 units at $2.69), increasing direct ownership by 37% to 6,441 units (SEC Form 4)
4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
INSIDER16:34:34·16h·Health Care·
$PCSA
Chief Development Officer Bigora Sian bought $5,342 worth of shares (1,986 units at $2.69), increasing direct ownership by 36% to 7,496 units (SEC Form 4)
4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
INSIDER16:31:02·16h·Technology·
$AUID
Director Garchik Stephen Jeffrey bought $150,000 worth of shares (120,482 units at $1.25) (SEC Form 4)
4 - authID Inc. (0001534154) (Issuer)
INSIDER16:30:29·16h·Technology·
$AUID
Director Jisser Ken bought $37,499 worth of shares (30,120 units at $1.25), increasing direct ownership by 33% to 122,245 units (SEC Form 4)
4 - authID Inc. (0001534154) (Issuer)
PR16:20:00·16h·Finance·
$EFX
Equifax Announces Participation in Upcoming Investor Conferences
ATLANTA, May 1, 2026 /PRNewswire/ -- Equifax® (NYSE:EFX) will participate in several upcoming investor conferences in May and June. Mark W. Begor, Chief Executive Officer, and John Gamble, Chief Financial Officer, will participate in the Baird 2026 Global Consumer, Technology & Services Conference on Tuesday, June 2, 2026 including participation in a Fireside Chat at 10:50 a.m., Eastern Time and the William Blair 2026 Growth Stock Conference on Wednesday, June 3, 2026, including participation in a Fireside Chat at 9:40 a.m., Eastern Time. The company invites investors to join a
INSIDER16:15:13·16h·Finance·
$XZO
Chief Executive Officer Patel Paresh bought $31,820 worth of shares (2,000 units at $15.91), increasing direct ownership by 0.12% to 1,636,013 units (SEC Form 4)
4 - Exzeo Group, Inc. (0001873951) (Issuer)
INSIDER16:13:43·16h·Basic Materials·
$IP
Director Tozier Scott bought $313,009 worth of shares (10,000 units at $31.30), increasing direct ownership by 40,000% to 10,025 units (SEC Form 4)
4 - INTERNATIONAL PAPER CO /NEW/ (0000051434) (Issuer)
INSIDER16:10:08·16h·Industrials·
$TXT
Director Kennedy Thomas A bought $988,594 worth of shares (10,300 units at $95.98) and was granted 2,061 shares, increasing direct ownership by 158% to 20,162 units (SEC Form 4)
4 - TEXTRON INC (0000217346) (Issuer)
INSIDER16:10:12·16h·Health Care·
$AIMD
Director Chiang Yao-Chung bought $511 worth of shares (300 units at $1.70) (SEC Form 4)
4 - Ainos, Inc. (0001014763) (Issuer)